24 April, 2024

Comprehensive Guide to Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI)

Chronic Total Occlusion (CTO) presents one of the most challenging conditions for interventional cardiologists. A CTO occurs when a coronary artery is completely blocked for at least three months. These blockages are often characterized by heavy calcification and a long duration of occlusion, which complicate revascularization efforts.

Understanding CTO PCI

Percutaneous Coronary Intervention (PCI) for CTO involves reopening the blocked coronary artery using various catheters and wires. This procedure aims to restore blood flow to the deprived segments of the heart muscle, improving patient symptoms and overall heart function. The complexity of CTOs requires innovative techniques and specialized equipment to achieve success.

Characteristics of CTO

CTOs are complex because they involve hardened, dense plaque that completely obstructs the artery. The presence of a CTO often leads to the development of collateral arteries, which are smaller, secondary pathways that develop over time to bypass the blockage and maintain blood flow to the heart muscle. While these collaterals can partially compensate for the lack of blood flow, they are usually not sufficient to fully supply the affected myocardium, especially during increased demand like physical activity.

Clinical Impact of CTO

Patients with CTOs frequently experience angina, fatigue, and reduced physical capacity. Additionally, CTOs can significantly impair the heart’s pumping efficiency, potentially leading to heart failure if left untreated.

Diagnosis of CTO

Diagnosing a CTO involves a combination of patient history, physical examination, and diagnostic tests including:

  • Electrocardiogram (ECG): Can show signs of past heart attacks or ongoing myocardial ischemia.
  • Echocardiography: Assesses the heart’s structure and function, identifying areas of reduced motion of the heart walls.
  • Coronary Angiography: The definitive test for diagnosing CTO, providing detailed images of the coronary arteries to identify the location and severity of blockages.
  • Cardiac CT and MRI: These imaging modalities provide additional information about the coronary arteries and heart muscle, especially in assessing the viability of the myocardium affected by the CTO.

Treatment Options for CTO

The primary treatment for CTO is revascularization, which can be achieved through:

  1. Percutaneous Coronary Intervention (PCI): This is the most common approach and involves using balloons, stents, and specialized devices like guidewires to reopen the blocked artery.
  2. Coronary Artery Bypass Grafting (CABG): In cases where PCI is not feasible or fails, CABG may be recommended. This involves using a vessel from another part of the body to create a new route around the blocked artery.

Challenges in Treating CTO

Treating CTO is more challenging than other types of coronary artery disease due to:

  • The hardness and length of the blockage.
  • The presence of a large amount of calcified plaque.
  • Difficulty in identifying the precise entry and exit points of the occluded segment.
  • The risk of complications such as artery perforation, dissection, or acute closure of the artery.

Case Study: Antegrade CTO PCI with Asahi Gaia Next 2 Guidewire and Recross Re-entry Catheter

Patient Background

  • Age/Sex: 67-year-old female
  • Medical History: Obese, multimorbid with progressive angina and moderate left ventricular (LV) dysfunction
  • Diagnosis: Multivessel Coronary Artery Disease (CAD) with a long segment calcified CTO in the distal right coronary artery (RCA)

Procedure Summary

The patient was planned for an antegrade technique using bilateral access. The primary challenges included the ambiguous proximal cap and the distal landing zone at a bifurcation, which required precise navigation and support.

Procedure Steps:

  1. Initial Access and Wire Escalation:
    • Antegrade wire escalation (AWE) began with the Fielder XT-A guidewire, followed by the newly launched Asahi Gaia Next 2 guidewire, supported by a Finecross microcatheter.
  2. Subintimal Crossing and Re-entry:
    • The procedure encountered subintimal tracking, which necessitated the use of the Recross re-entry device, enabling successful re-entry into the true lumen using the Gaia Next guidewire.
  3. Completion and Results:
    • The procedure was completed successfully, restoring blood flow with good angiographic results.

 

Frequently Asked Questions (FAQs)

What are the risks associated with CTO PCI?

The risks include but are not limited to vessel damage, emergency coronary artery bypass graft surgery (CABG), myocardial infarction, and radiation exposure.

How long does recovery take after a CTO PCI?

Recovery can vary but typically involves a short hospital stay followed by several weeks of gradual return to normal activities, depending on the individual’s overall health and the complexity of the procedure.

How successful is CTO PCI?

Success rates vary based on the complexity of the occlusion and the technique used, but they have been improving significantly with new technologies and techniques, currently ranging from 70 to 90%.

Who is a candidate for CTO PCI?

Patients with symptomatic heart disease attributable to a CTO, who have viable myocardium in the territory supplied by the occluded vessel, are considered potential candidates. Decisions are typically made by a heart team, considering all therapeutic options.

This detailed examination of CTO PCI, bolstered by a recent case study, illustrates the advancements in the field and the ongoing commitment to improving patient outcomes in interventional cardiology.

Share